Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice?

B Buchard, Y Boirie, L Cassagnes, G Lamblin, A Coilly… - Nutrients, 2020 - mdpi.com
Malnutrition is a common comorbidity in patients with cirrhosis. Its prognostic value is
indisputable as it greatly affects the evolution of liver diseases. It has a major impact on both …

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

R Jalan, G D'Amico, J Trebicka, R Moreau, P Angeli… - Journal of …, 2021 - Elsevier
Traditionally, the complications of cirrhosis, namely variceal bleeding, ascites and hepatic
encephalopathy, were thought to result predominantly from circulatory dysfunction and …

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

[PDF][PDF] Redefining cirrhotic cardiomyopathy for the modern era

M Izzy, LB VanWagner, G Lin, M Altieri, JY Findlay… - …, 2020 - Wiley Online Library
Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver
disease in the absence of prior heart disease. First defined in 2005 during the World …

Diagnosis and management of cirrhotic cardiomyopathy

H Kaur, M Premkumar - Journal of Clinical and Experimental Hepatology, 2022 - Elsevier
Background Cirrhotic cardiomyopathy refers to the structural and functional changes in the
heart leading to either impaired systolic, diastolic, electrocardiographic, and neurohormonal …

An update on cirrhotic cardiomyopathy

S Møller, KV Danielsen, S Wiese, JD Hove… - Expert review of …, 2019 - Taylor & Francis
Introduction: Cirrhosis with portal hypertension and related complications are associated
with a high mortality. Excess of circulating vasodilators and cardiodepressive substances …

[PDF][PDF] Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt

MC Meucci, MM Hoogerduijn Strating… - Hepatology …, 2022 - Wiley Online Library
The present study aimed to investigate (1) the association between left ventricular diastolic
dysfunction (LVDD), graded according to the algorithm proposed by the Cirrhotic …

How non-alcoholic fatty liver disease and cirrhosis affect the heart

S Møller, S Wiese, M Barløse, JD Hove - Hepatology International, 2023 - Springer
Liver diseases affect the heart and the vascular system. Cardiovascular complications
appear to be a leading cause of death in patients with non-alcoholic fatty liver disease …

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

M Cesari, AC Frigo, S Piano, P Angeli - Clinical and Experimental …, 2021 - termedia.pl
Results Adequate echocardiographic images permitting speckle tracking analysis were
available in 83 patients. No patient presented LVEF≤ 50%, GLS< 18% or> 22% was …

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

S Wiese, J Hove, S Mo, RP Mookerjee… - Liver …, 2018 - Wiley Online Library
Abstract Background & Aims The underlying pathogenesis of cirrhotic cardiomyopathy
remains unclear. Structural myocardial changes including diffuse fibrosis may be involved …